{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:37:21Z","timestamp":1789522641137,"version":"build-2803163510"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria","award":["project \u2116 BG-RRP-2.004-0004-C01."],"award-info":[{"award-number":["project \u2116 BG-RRP-2.004-0004-C01."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Novel pyrrole-based derivatives were synthesized in high purity and yields (52\u201389%), with 17i and 17j displaying selective MAO-B inhibition (50\u201360%), comparable to Selegiline, and negligible MAO-A activity. In rat brain subcellular fractions, both compounds showed low intrinsic neurotoxicity at 100 \u03bcM while exerting significant neuroprotective and antioxidant effects under 6-OHDA, t-BuOOH, and Fe2+\/ascorbate-induced stress. Mechanistic studies indicate dual protection via reactive oxygen species scavenging and preservation of reduced glutathione, with mitochondria and microsomes being the most responsive compartments. The performed in silico analysis revealed no general toxicity alerts, though hydrazine groups classify the compounds as contact allergens, and the furan ring in 17i poses hepatotoxic and carcinogenic risks. Metabolic predictions suggest ester hydrolysis at the pyrrole ring as the main biotransformation pathway. Overall, 17i and 17j are promising lead compounds for developing therapeutics targeting oxidative stress-related neurodegenerative diseases, such as Parkinson\u2019s and Alzheimer\u2019s, supporting further in vivo studies.<\/jats:p>","DOI":"10.3390\/molecules31010186","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:03:48Z","timestamp":1767607428000},"page":"186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Pyrrole Heterocyclic Derivatives as Selective MAO-B Inhibitors and Neuroprotectors"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-5002","authenticated-orcid":false,"given":"Maya","family":"Georgieva","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sharkov","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-7213","authenticated-orcid":false,"given":"Emilio","family":"Mateev","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1905-7130","authenticated-orcid":false,"given":"Alexandrina","family":"Mateeva","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-0870","authenticated-orcid":false,"given":"Magdalena","family":"Kondeva-Burdina","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","article-title":"Monoamine oxidase isoenzymes: Genes, functions and targets for behavior and cancer therapy","volume":"125","author":"Shih","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Nordio, G., Piazzola, F., Cozza, G., Rossetto, M., Cervelli, M., Minarini, A., Basagni, F., Tassinari, E., Dalla Via, L., and Milelli, A. (2023). From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs. Molecules, 28.","DOI":"10.20944\/preprints202308.0458.v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","article-title":"Distribution of monoamine oxidase proteins in human brain: Implications for brain imaging studies","volume":"33","author":"Tong","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Behl, T., Kaur, D., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Andronie-Cioara, F.L., Toma, M.M., Bungau, S., and Bumbu, A.G. (2021). Role of Monoamine Oxidase Activity in Alzheimer\u2019s Disease: An Insight into the Therapeutic Potential of Inhibitors. Molecules, 26.","DOI":"10.3390\/molecules26123724"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Carradori, S., Fantacuzzi, M., Ammazzalorso, A., Angeli, A., De Filippis, B., Galati, S., Petzer, A., Petzer, J.P., Poli, G., and Tuccinardi, T. (2022). Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?. Molecules, 27.","DOI":"10.3390\/molecules27227816"},{"key":"ref_6","unstructured":"Sabri, M.A., and Saber-Ayad, M.M. (2024). MAO Inhibitors. StatPearlsi, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.38184.606169.AE","article-title":"Monoamine oxidase type B inhibitors in early Parkinson\u2019s disease: Meta-analysis of 17 randomised trials involving 3525 patients","volume":"329","author":"Ives","year":"2004","journal-title":"Br. Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e202200370","DOI":"10.1002\/slct.202200370","article-title":"Synthesis, Characterization, Molecular Docking, Acetylcholinesterase and \u03b1-Glycosidase Inhibition Profiles of Nitrogen-Based Novel Heterocyclic Compounds","volume":"7","author":"Gulcin","year":"2022","journal-title":"ChemistrySelect"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Puranik, N., and Song, M. (2025). Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer\u2019s and Parkinson\u2019s Diseases. Neurol. Int., 17.","DOI":"10.3390\/neurolint17020026"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.56782\/pps.235","article-title":"Synthesis of pyrazole and 1,3,4-oxadiazole derivatives of pharmaceutical potential","volume":"22","author":"Kadam","year":"2024","journal-title":"Prospect. Pharm. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pibiri, I. (2024). Recent Advances: Heterocycles in Drugs and Drug Discovery. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179503"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e202400738","DOI":"10.1002\/slct.202400738","article-title":"Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review","volume":"9","author":"Chauhan","year":"2024","journal-title":"ChemistrySelect"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Martins, P., Jesus, J., Santos, S., Raposo, L.R., Roma-Rodrigues, C., Baptista, P.V., and Fernandes, A.R. (2015). Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine\u2019s Tool Box. Molecules, 20.","DOI":"10.3390\/molecules200916852"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0161-813X(02)00093-1","article-title":"Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity","volume":"23","author":"Stokes","year":"2002","journal-title":"Neurotoxicology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rynkowska, A., St\u0119pniak, J., and Karbownik-Lewi\u0144ska, M. (2020). Fenton Reaction-Induced Oxidative Damage to Membrane Lipids and Protective Effects of 17\u03b2-Estradiol in Porcine Ovary and Thyroid Homogenates. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17186841"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1471-4159.2000.0750141.x","article-title":"Trans-Resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: Electron paramagnetic resonance spin trapping evidence for a rdical scavenging mechanism","volume":"75","author":"Karlsson","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.33549\/physiolres.930578","article-title":"Tert-butyl hydroperoxide selectively inhibits mitochondrial respiratory-chain enzymes in isolated rat hepatocytes","volume":"54","author":"Drahota","year":"2005","journal-title":"Physiol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0300-483X(03)00266-X","article-title":"Chemical substances and contact allergy\u2014244 substances ranked according to allergenic potency","volume":"193","author":"Schlede","year":"2003","journal-title":"Toxicology"},{"key":"ref_19","unstructured":"International Agency for Research on Cancer (IARC) (1995). Furan. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (IARC)."},{"key":"ref_20","first-page":"82","article-title":"Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase\/monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease","volume":"21","author":"Esteban","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1046\/j.1471-4159.1994.62041586.x","article-title":"Subcellular fractionation on Percoll gradient of mossy fiber synaptosomes: Morphological and biochemical characterization in control and degranulated rat hippocampus","volume":"62","author":"Taupin","year":"1994","journal-title":"J. Neurochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jnr.10193","article-title":"\u03b2-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine","volume":"68","author":"Ferrera","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0003-9861(71)90334-1","article-title":"Reaction of protein disulfide groups with Ellman\u2019s reagent: A case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae \u03b1-amylase, papain, and lysozyme","volume":"147","author":"Robyt","year":"1971","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1007\/s11356-018-04119-5","article-title":"The ameliorative effect of quercetin on bisphenol A-induced toxicity in mitochondria isolated from rats","volume":"26","author":"Shirani","year":"2019","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0003-2697(90)90461-H","article-title":"Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method","volume":"187","author":"Ravindranath","year":"1990","journal-title":"Anal. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0006-291X(86)91029-6","article-title":"A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione","volume":"135","author":"Mansuy","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/1\/186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:12:59Z","timestamp":1767676379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/1\/186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["molecules31010186"],"URL":"https:\/\/doi.org\/10.3390\/molecules31010186","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]}}}